Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
143.00
Ask:
145.00
Spread: 2.00 (1.399%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

16 Apr 2009 07:00

RNS Number : 6219Q
Xaar PLC
16 April 2009
 



FOR IMMEDIATE RELEASE

16 April 2009

Xaar plc

INTERIM MANAGEMENT STATEMENT

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 January 2009 to 31 March 2009. 

Trading for the first quarter of the year, historically the Group's quietest trading period due to the Chinese New Year holiday in February, was in line with the Board's expectations at a level similar to that for Q1, 2008 and was stable at the levels seen in the third and fourth quarters of 2008.

 

The first of Xaar’s new second generation Platform 1 products, the Xaar Proton, was successfully launched during the period at the Sign China show in Guangzhou. Following the launch, sales of the Proton into China have been ahead of the Board’s expectations. The Proton will be released into India and Latin America during the course of 2009 as the Group’s OEM customers in those regions launch new printing machines incorporating the printheads. The Xaar Electron, the second new Platform 1 product, remains on course for its launch in customer printing machines at the Shanghai Ad show in early July.

Original Equipment Manufacturers in western markets continue to launch printing machines based on Xaar's Platform 3 (P3) technology with further product launches during the period. Whilst the number of OEM customers bringing printing machines based on P3 technology to market is encouraging, the transition from product launch to volume sales remains slow and cannot be expected to be immune from the effects of the global economic situation.

The Group has maintained its strong balance sheet throughout the period with gross cash at 31 March 2009 of £12.4m (31 December 2008: £11.6m). Total debt at 31 March 2009 was £0.6m (31 December 2008: £0.6m). The cash inflow during the period reflects both stable trading and the benefits of previously announced cost saving measures.

On 1 April 2009 the Group announced the rationalisation of its manufacturing facilities which will involve the eventual closure of its plant in StockholmSweden and the relocation of that manufacturing capability to the Group's manufacturing facility in HuntingdonEngland. This process is expected to take up to two years to complete and is expected to result in a substantial reduction in the Group's cost base.

The Board is encouraged by trading in Q1 but, given both a continuing lack of visibility of customer orders and the current uncertainty in the business environment due to the ongoing global economic situation, must remain cautious when looking forward. 

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

Bankside Consultants:

Steve Liebmann

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDSDBBGGCU
Date   Source Headline
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights
28th Mar 20237:00 amRNSFinal Results
20th Mar 20232:00 pmRNSNotification of the 2022 Full Year Results Date
1st Mar 20233:19 pmRNSTotal Voting Rights
20th Feb 202312:35 pmRNSHolding(s) in Company
1st Feb 202312:30 pmRNSTotal Voting Rights
30th Jan 202312:30 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTrading Update
5th Dec 202210:21 amRNSDirector/PDMR Shareholding
1st Dec 202210:19 amRNSTotal Voting Rights
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20221:38 pmRNSGrant of Sharesave Options
1st Nov 202210:41 amRNSTotal Voting Rights
13th Oct 20222:20 pmRNSHolding(s) in Company
3rd Oct 20224:07 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNS2022 INTERIM RESULTS
1st Sep 20225:32 pmRNSTotal Voting Rights
30th Aug 202210:26 amRNSNotice of 2022 Half Year Results
1st Aug 20224:33 pmRNSTotal Voting Rights
1st Aug 202211:25 amRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
1st Jul 20221:14 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.